Total Payments
$13,094
2024 Payments
$1,509
Companies
51
Transactions
811
Medicare Patients
5,522
Medicare Billing
$651,291
Payment Breakdown by Category
Food & Beverage$12,891 (98.4%)
Education$182.60 (1.4%)
Other$21.34 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,891 | 795 | 98.4% |
| Education | $182.60 | 15 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21.34 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,789 | 85 | $0 (2024) |
| Novo Nordisk Inc | $1,210 | 102 | $0 (2024) |
| Lilly USA, LLC | $1,116 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,045 | 62 | $0 (2024) |
| PFIZER INC. | $944.20 | 49 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $916.57 | 50 | $0 (2024) |
| Amgen Inc. | $884.05 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $689.05 | 54 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $540.58 | 30 | $0 (2023) |
| ABBVIE INC. | $453.43 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,509 | 80 | Novo Nordisk Inc ($338.89) |
| 2023 | $1,379 | 80 | Novo Nordisk Inc ($193.11) |
| 2022 | $1,661 | 96 | GlaxoSmithKline, LLC. ($308.64) |
| 2021 | $1,769 | 123 | Ironwood Pharmaceuticals, Inc ($224.99) |
| 2020 | $1,336 | 86 | AstraZeneca Pharmaceuticals LP ($274.64) |
| 2019 | $1,117 | 68 | Amgen Inc. ($231.96) |
| 2018 | $1,961 | 127 | PFIZER INC. ($423.99) |
| 2017 | $2,362 | 151 | AstraZeneca Pharmaceuticals LP ($348.89) |
All Payment Transactions
811 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: GI | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: UROLOGY | ||||||
| 11/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Obesity | ||||||
| 10/28/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: GI | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: UROLOGY | ||||||
| 09/24/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: GI | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $23.57 | General |
| Category: Allergy/Immunology | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,093 | 2,255 | $248,520 | $118,446 |
| 2022 | 24 | 1,320 | 2,597 | $298,728 | $151,488 |
| 2021 | 23 | 1,353 | 2,959 | $365,141 | $195,682 |
| 2020 | 24 | 1,756 | 3,692 | $338,376 | $185,675 |
Total Patients
5,522
Total Services
11,503
Medicare Billing
$651,291
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 628 | $110,240 | $56,311 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 446 | $69,310 | $28,180 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $10,580 | $9,858 | 93.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 37 | $12,950 | $8,061 | 62.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 46 | 88 | $3,960 | $2,293 | 57.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 40 | 55 | $3,025 | $2,230 | 73.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 41 | $8,323 | $1,863 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 158 | $6,320 | $1,679 | 26.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 37 | 96 | $5,280 | $1,557 | 29.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 80 | 80 | $2,400 | $1,471 | 61.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 129 | 188 | $1,631 | $1,451 | 89.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $985.00 | $875.00 | 88.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 37 | 40 | $5,000 | $848.18 | 17.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 52 | $1,560 | $495.04 | 31.7% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 17 | 17 | $1,156 | $346.26 | 30.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 28 | $2,100 | $303.31 | 14.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 13 | 19 | $570.00 | $285.19 | 50.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 39 | 55 | $550.00 | $187.55 | 34.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 17 | 17 | $595.00 | $65.79 | 11.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 18 | 20 | $200.00 | $64.20 | 32.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 22 | 37 | $1,295 | $15.55 | 1.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 24 | 49 | $490.00 | $4.46 | 0.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 894 | $156,625 | $81,962 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 425 | $66,235 | $27,506 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 98 | 98 | $13,622 | $13,022 | 95.6% |
About Dr. Sami Abufarha, MD
Dr. Sami Abufarha, MD is a Internal Medicine healthcare provider based in Dearborn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104895697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sami Abufarha, MD has received a total of $13,094 in payments from pharmaceutical and medical device companies, with $1,509 received in 2024. These payments were reported across 811 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($12,891).
As a Medicare-enrolled provider, Abufarha has provided services to 5,522 Medicare beneficiaries, totaling 11,503 services with total Medicare billing of $651,291. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Dearborn, MI
- Active Since 03/16/2006
- Last Updated 12/31/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104895697
Products in Payments
- Linzess (Drug) $819.14
- FARXIGA (Drug) $717.27
- Ozempic (Drug) $517.86
- TRELEGY ELLIPTA (Drug) $453.87
- JARDIANCE (Drug) $439.67
- TRULICITY (Drug) $417.48
- CHANTIX (Drug) $405.08
- XIFAXAN (Drug) $361.26
- Aimovig (Biological) $323.67
- TRADJENTA (Drug) $317.30
- BREZTRI (Drug) $305.33
- GEMTESA (Drug) $266.96
- EMGALITY (Drug) $266.31
- LINZESS (Drug) $252.13
- Prolia (Biological) $248.07
- EVENITY (Biological) $243.80
- AIRSUPRA (Drug) $231.40
- ELIQUIS (Drug) $215.95
- JANUVIA (Drug) $207.04
- MOUNJARO (Drug) $200.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dearborn
Wassim Younes, Md, Rph, MD, RPH
Internal Medicine — Payments: $215,063
Internal Medicine $215,063
Abdulhassan Saad, M.d, M.D
Internal Medicine — Payments: $199,745
Internal Medicine $199,745
Ziad Berri, Md, MD
Internal Medicine — Payments: $47,432
Internal Medicine $47,432
Dr. Opada Alzohaili, Md, MD
Internal Medicine — Payments: $39,452
Internal Medicine $39,452
Mohamad Khansa
Internal Medicine — Payments: $36,417
Internal Medicine $36,417
Dr. Mazen Elatrache, Md, MD
Internal Medicine — Payments: $28,467
Internal Medicine $28,467